The general trend shows that plasma exposure to the free acid of travoprost after local administration of travoprost is extremely low in all age groups that were evaluated.
No information is present at this moment.
No information is present at this moment.
| Glaucoma |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Ocular hyperaemia, eyelash growth, eyelid erythema, keratitis, increased tear production and photophobia
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Parasympathomimetics | ||
|---|---|---|
| S01EB01 | ||
| Carbonic anhydrase inhibitors | ||
|---|---|---|
| S01EC01 | ||
| S01EC03 | ||
| Beta blocking agents | ||
|---|---|---|
| S01ED01 | ||
| Prostaglandin analogues | ||
|---|---|---|
| S01EE03 | ||
| S01EE01 | ||
| Other antiglaucoma preparations | ||
|---|---|---|
| S01EX | ||
| OTHER ANTIGLAUCOMA PREPARATIONS | ||
|---|---|---|
| S01EX | ||